ArticleFrontiers in medicine2026

Long-term monthly mesenchymal stromal cell therapy for advanced chronic lung allograft dysfunction: a single-centre safety and feasibility cohort study.

Sara Lettieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.